Cargando…

Patient decisions for disclosure of secondary findings among the first 200 individuals undergoing clinical diagnostic exome sequencing

PURPOSE: Exome sequencing of a single individual for a clinical indication may result in the identification of incidental deleterious variants unrelated to the indication for testing (secondary findings). Given the recent availability of clinical exome testing, there is a limited knowledge regarding...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shahmirzadi, Layla, Chao, Elizabeth C., Palmaer, Erika, Parra, Melissa C., Tang, Sha, Gonzalez, Kelly D. Farwell
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2014
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4018499/ https://www.ncbi.nlm.nih.gov/pubmed/24113345 http://dx.doi.org/10.1038/gim.2013.153

Ejemplares similares

When moments matter: Finding answers with rapid exome sequencing
por: Powis, Zöe, et al.
Publicado: (2019)

Clinical whole‐exome sequencing results impact medical management
por: Niguidula, Nancy, et al.
Publicado: (2018)

Exome sequencing covers >98% of mutations identified on targeted next generation sequencing panels
por: LaDuca, Holly, et al.
Publicado: (2017)

Clinical diagnostic exome evaluation for an infant with a lethal disorder: genetic diagnosis of TARP syndrome and expansion of the phenotype in a patient with a newly reported RBM10 alteration
por: Powis, Zöe, et al.
Publicado: (2017)

Candidate-gene criteria for clinical reporting: diagnostic exome sequencing identifies altered candidate genes among 8% of patients with undiagnosed diseases
por: Farwell Hagman, Kelly D., et al.
Publicado: (2017)

Correction: Candidate-gene criteria for clinical reporting: diagnostic exome sequencing identifies altered candidate genes among 8% of patients with undiagnosed diseases
por: Farwell Hagman, Kelly D, et al.
Publicado: (2018)

A retrospective review of multiple findings in diagnostic exome sequencing: half are distinct and half are overlapping diagnoses
por: Smith, Erica D., et al.
Publicado: (2019)

Actionable Exomic Secondary Findings in 280 Lebanese Participants
por: Jalkh, Nadine, et al.
Publicado: (2020)

Secondary findings in 421 whole exome-sequenced Chinese children
por: Chen, Wen, et al.
Publicado: (2018)

Frequency and spectrum of actionable pathogenic secondary findings in Taiwanese exomes
por: Kuo, Chieh‐Wen, et al.
Publicado: (2020)

Influence of data disclosures on physician decisions about off-label uses: findings from a qualitative study
por: Chansky, Melanie C., et al.
Publicado: (2022)

A systematic literature review of disclosure practices and reported outcomes for medically-actionable genomic secondary findings
por: Sapp, Julie C., et al.
Publicado: (2021)

Ethical values supporting the disclosure of incidental and secondary findings in clinical genomic testing: a qualitative study
por: Saelaert, Marlies, et al.
Publicado: (2020)

A Scoping Review of Global Guidelines for the Disclosure of Secondary Genomic Findings to Inform the Establishment of Guidelines in China
por: Jiang, Shan
Publicado: (2022)

Autistic adults’ experiences of diagnostic disclosure in the workplace: Decision-making and factors associated with outcomes
por: Romualdez, Anna Melissa, et al.
Publicado: (2021)

Classification of Genes: Standardized Clinical Validity Assessment of Gene–Disease Associations Aids Diagnostic Exome Analysis and Reclassifications
por: Smith, Erica D., et al.
Publicado: (2017)

HIV disclosure to surrogate decision makers: privacy versus presumption
por: Lott, Jason P
Publicado: (2007)

Feasibility of virtual Alzheimer's biomarker disclosure: Findings from an observational cohort
por: Erickson, Claire M., et al.
Publicado: (2023)

Whether, when, how, and how much? General public’s and cancer patients’ views about the disclosure of genomic secondary findings
por: Cléophat, Jude Emmanuel, et al.
Publicado: (2021)

Exome Sequencing in 200 Intellectual Disability/Autistic Patients: New Candidates and Atypical Presentations
por: Valentino, Floriana, et al.
Publicado: (2021)

Guidance for reconciling patent rights and disclosure of findings at scientific meetings
por: Lipkus, Nathaniel B, et al.
Publicado: (2010)

Funding considerations for the disclosure of genetic incidental findings in biobank research
por: Black, L, et al.
Publicado: (2013)

Clinical decision-making and secondary findings in systems medicine
por: Fischer, T., et al.
Publicado: (2016)

Disclosures
Publicado: (2016)

Correction - Author Disclosures
por: Venkata, C.
Publicado: (2009)

A commentary on Actionable secondary findings in the 73 ACMG-recommended genes in 1,559 Thai exomes
por: Johnston, Jennifer J., et al.
Publicado: (2022)

Participant use and communication of findings from exome sequencing: A mixed methods study: Use and communication of findings from exome sequencing
por: Lewis, Katie L., et al.
Publicado: (2015)

A systematic approach to the disclosure of genomic findings in clinical practice and research: a proposed framework with colored matrix and decision-making pathways
por: Matsui, Kenji, et al.
Publicado: (2021)

Theoretical conceptualization of online privacy-related decision making – Introducing the tripartite self-disclosure decision model
por: Ostendorf, Sina, et al.
Publicado: (2022)

Clinical exome-based panel testing for medically actionable secondary findings in a cohort of 383 Italian participants
por: Martone, Stefania, et al.
Publicado: (2022)

Exome sequencing findings in children with annular pancreas
por: Pitsava, Georgia, et al.
Publicado: (2023)

Finding Keys: A Systematic Review of Barriers and Facilitators for Refugee Children’s Disclosure of Their Life Stories
por: van Os, E. C. C. (Carla), et al.
Publicado: (2018)

Actionable exomic incidental findings in 6503 participants: challenges of variant classification
por: Amendola, Laura M., et al.
Publicado: (2015)

Multi-Phenotypic Breast Cancer Post-Radiotherapy for Hodgkin Lymphoma: A Case of Secondary Malignancy
por: White, Donnell, et al.
Publicado: (2023)

Disclosures Undisclosed
por: Janney, Cory F., et al.
Publicado: (2019)

Clarification of Disclosure
Publicado: (2022)

Your Biobank, Your Doctor?: The right to full disclosure of population biobank findings
por: Bovenberg, J. A., et al.
Publicado: (2009)

Disclosure of Sexual Victimization: Effects of Invalidation and Shame on Re-Disclosure
por: Catton, Ashley K. H., et al.
Publicado: (2023)

(Non-)disclosure of lifetime sexual violence in maternity care: Disclosure rate, associated characteristics and reasons for non-disclosure
por: de Klerk, Hannah W., et al.
Publicado: (2023)

Blockchain’s role in e-commerce sellers’ decision-making on information disclosure under competition
por: Song, Yuguang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fe2uloujsnmic3thrl04pvo3e7